SARS-CoV-2

Booster shots with COVID-19 mRNA outperformed inactivated virus by eliciting stronger antibody responses to the Omicron variant.

Vaccinated people affected by COVID-19 variants have different memory B cell responses than their close contacts who remain healthy.

Molecular simulations uncover a new druggable pocket in SARS-CoV-2’s spike protein which could hold the key to blocking COVID-19 infections.

A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe COVID-19 cases.

A profile of the immune responses from Singaporean patients recovered from COVID-19 has revealed an urgent need to update vaccines against new viral variants.

A deletion in the genome of SARS-CoV-2 variants makes resulting infections milder and could also be a target for future COVID-19 treatments.

A head-to-head test of three common mask decontamination methods helps frame standardised national guidelines.

New self-cleaning surfaces created by A*STAR researchers take inspiration from cicada wings to attract and destroy microbes without harsh chemicals.

A*STAR researchers blend the physics of particle dynamics with complex computational simulations to gauge the risk of catching COVID-19 in different social settings.

A*STAR researchers develop a standardised, self-administered taste and smell test for detecting the early symptoms of COVID-19.

Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able to mount a strong immune response against infections.

A*STAR researchers create a next-generation, ultrasensitive COVID-19 rapid test powered by gold nanoparticles.